tailieunhanh - Locally ablative treatment of breast cancer liver metastases: Identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)

Liver metastases from breast cancer (LMBC) are typically considered to indicate systemic disease spread and patients are most often offered systemic palliative treatment only. However, retrospective studies suggest that some patients may have improved survival with local treatment of their liver metastases compared to systemic therapy alone. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN